Effective ultra-low doses of erlotinib in patients with EGFR sensitising mutation

Weronika Maria Szejniuk(Aalborg University Hospital), Oluf Dimitri Røe(Norwegian University of Science and Technology), Tine McCulloch(Aalborg University Hospital)
BMJ Case Reports
July 23, 2014
Cited by 4


Related Papers